THE TAM is possibly $4b now with TBI. I envisage that our drug may be used routinely for every brain neurosurgical procedure. The patients are given antibiotics plus our drug to help reduce intracranial pressure. And they might receive it in reducing doses for 5 to 7 days. That scenario would add a few billion to the TAM.
Ann: Invex Granted European Orphan Drug Designation for TBI, page-57
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
